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Abstract 
A choriocarcinoma component with a malignant tumor is relatively rare. We present a case of 
an 85-year-old woman with mixed carcinoma, which was endometrioid adenocarcinoma with 
squamous differentiation, choriocarcinoma and a disseminated peritoneal nodule, which was 
papillary serous adenocarcinoma. The patient received surgery and conservative treatment. 
Twenty weeks after surgery, a recurring tumor appeared at the Douglas pouch. Histology 
showed that the recurring tumor was poorly differentiated carcinoma that was very different 
from  the  primary  tumor.  This  case  represents  an  unusual  uterine  corpus  cancer  with 
high-grade transformation with serous and choriocarcinomatous differentiation. This case 
also demonstrates the capacity of tumor cells to differentiate into divergent elements. 
Key words: hCG, choriocarcinoma, endometrial cancer, squamous cell carcinoma, trophoblastic 
tumor. 
Introduction  
Most  cases  of  choriocarcinoma  occur  in  the 
uterine body and arise from chorionic villi following a 
normal  or abnormal gestation. Non-gestational cho-
riocarcinoma is relatively rare. Endometrioid adeno-
carcinoma of the uterine corpus with another histo-
logical type is usually squamous cell carcinoma, se-
rous or clear cell adenocarcinoma and sarcoma, and 
there  have  been  a  few  reports  of  choriocarcinoma 
[1-3]. We report a patient who had mixed cancer with 
three  distinct  histological  types:  endometrioid  ade-
nocarcinoma  with  squamous  differentiation,  chori-
ocarcinoma in the uterine body and a disseminated 
peritoneal  nodule  showing  papillary  serous  adeno-
carcinoma.  
Case report  
An 85-year old woman, gravida 5, parity 2 with 
menopausal status for 27 years presented with post-
menopausal  bleeding.  A  physical  examination  re-
vealed a bulky uterus with pyometra. A subsequent 
transvaginal  ultrasound showed  an  endometrial  mass, 
measuring  approximately  1.8  cm  in  diameter.  Mag-
netic resonance imaging showed a mass in the uterine 
cavity with myometrial invasion, which is consistent 
with the ultrasound findings. 
Using [18F]fluoro-2-deoxy-D-glucose (18F-FDG) 
positron  emission  tomography  (PET)  /  computed 
tomography (CT), we observed a uterine tumor with 
increased uptake and intense uptake in the left para-
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colic  region  indicating  peritoneal  dissemination, 
without signs of distant metastases. 
Serum hCG-β subunit, CA19-9 and CEA levels 
were  elevated  to  8.0  ng/ml  (normal,  <  0.1  ng/ml), 
127.6 U/ml (normal, < 37 U/ml), and 8.1 U/ml (nor-
mal, < 5 ng/ml), respectively. Serum CA-125 levels 
were within the normal range. 
In an endometrial biopsy  specimen, the tumor 
was diagnosed as serous or endometrioid adenocar-
cinoma. Under the diagnosis of endometrial cancer, 
total  abdominal  hysterectomy,  bilateral  salpin-
go-oophorectomy  and  multiple  biopsies  were  per-
formed. During laparotomy, the uterine fundus and 
body appeared mildly bulky. The surface of the sig-
moid colon was disseminated with several subcenti-
metric tumor foci. 
On  macroscopic  examination  of  the  uterine 
specimen, a huge ulceroinfiltrative necrotic mass was 
located  on  the  posterior  wall,  and  a  hemorrhagic 
nodule was located in the serosa of the uterine fundus 
and internal cervical os (Figure 1). 
A pathological examination revealed three dis-
tinct  histological  types.  Approximately  half  of  the 
tumor showed an endometrioid adenocarcinoma with 
squamous differentiation (Figure 2A, 2B). The hem-
orrhagic  nodule  showed  a  choriocarcinoma  compo-
nent with a two-cell pattern that had syncytiotropho-
blast-like  and  cytotrophoblast-like  elements  (Figure 
3A). Immunohistochemical staining for hCG-β subu-
nit  was  positive,  especially  in  the  syncytiotropho-
blast-like  element  (Figure  3B).  This  component  was 
indicative  of  choriocarcinoma.  Other  pathological 
elements  did  not  reveal  any  hCG-β  subu-
nit-producing  cells.  The  biopsy  specimen  derived 
from  peritoneal  dissemination  of  the  sigmoid  colon 
showed  a  serous  papillary  adenocarcinoma  (Figure 
4A). Positive immunohistochemical  nuclear staining 
of p53 was detected in three distinct histological types 
(Figure 2C, 2D, 3C and 4B). 
Considering the advanced age of the patient, adjuvant 
therapy was avoided. Twenty weeks later, serum hCG-β 
subunit was elevated to 55 ng/ml. Transvaginal ultra-
sound showed a 5.2 × 5.3 cm-sized cul-de-sac mass. 
Five months after surgery, the cul-de-sac  mass  was 
enlarged to 14.4 × 8.0 cm and caused rectosigmoid co-
lonic obstruction. The patient underwent diverting co-
lostomy  to  relieve  the  obstruction.  A  surgical  biopsy 
showed poorly differentiated carcinoma with mono-
nuclear cells (Figure 5A) without any primary patho-
logical  features,  although  immunohistochemical 
staining  for  hCG-β  subunitand  p53  was  positive  in 
part of the mononuclear cells, suggested cytotropho-
blastic differentiation (Figure 5B and 5C).  
 
 
Figure 1. Gross findings of the uterus. A huge ulceroinfiltrative necrotic mass measuring 40 × 40 mm is located on the 
posterior wall and a diffuse dark reddish hemorrhagic nodule (arrows) is located in the serosa of the uterine fundus and 
internal cervical os.   Journal of Cancer 2012, 3 
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Figure 2. The tumor shows endometrioid adenocarcinoma (A) with squamous differentiation (B). The same components in 
p53 stained sections (C, D).  
 
Figure 3. The choriocarcinoma component is composed of syncytiotrophoblast-like cells and cytotrophoblast-like cells (A). 
Immunohistochemical staining for hCG-β subunit of the choriocarcinoma component shows a positive reaction in syn-
cytiotrophoblast-like cells (B). The same components in p53-stained sections (C).  Journal of Cancer 2012, 3 
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Figure 4. Peritoneal dissemination of the sigmoid colon shows papillary serous adenocarcinoma (A) and p53 positivity (B). 
 
Figure 5. The recurring tumor shows poorly differentiated adenocarcinoma with numerous mitoses (A). Immunohisto-
chemical staining for hCG-β subunit and p53 shows a positive reaction in part of the mononuclear cells (B, C). 
 
Discussion 
The combination of choriocarcinoma and other 
histological  types  has  been  reported  in  association 
with  some  human  cancers,  predominantly  with  the 
female genital tract [1-3] and rarely with carcinomas 
of  the  esophagus  [4],  bladder  or  renal  pelvis  [5, 6], 
stomach [7], rectum [8], lung [9], and breast [10]. In 
gynecological  cases,  an  endometrioid  adenocarcino-
ma with a choriocarcinoma component is a rare event 
with a highly aggressive clinical course [2, 3].  
 In  our  case,  because  no  pre-existing  endome-
trium  and  endometrial  hyperplasia  localized  with 
squamous and choriocarcinoma lesion, we considered 
this case showed the primary tumor which had three 
components:  endometrioid  adenocarcinoma  with 
squamous  and  choriocarcinomatous  differentiation 
and  papillary  serous  adenocarcinoma.  Interestingly, 
the recurring tumor was poorly differentiated carci-
noma with mononuclear cells that were different from 
primary pathological features.  
For the mechanism of development of a mixed 
tumor including a component of a choriocarcinoma,  Journal of Cancer 2012, 3 
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three  hypotheses  have  been  postulated:  1) 
de-differentiation of epithelial cells into choriocarci-
nomas [1, 7, 11]; 2) germ cells that fail to complete 
their migration to the gonads [11]; and 3) multidirec-
tional tumor differentiation from a common stem cell 
[1]. Some researchers have suggested that some can-
cers may originate from cancer stem cells. Recently, a 
small  population  of  endometrial  epithelial 
stem/progenitor  cells  was  identified  in  normal  hu-
man  endometrium  [12,  13].  Several  studies  have 
found that the endometrioid adenocarcinoma cell line 
contains a subpopulation of tumor initiating cells with 
stem-like properties. It is likely that the bulk of cells 
within a tumor consist of stem/progenitor cells and 
more differentiated cells [3, 14, 15]. 
Our case presented with unique characteristics. 
The primary tumor showed three distinct histological 
types and the recurring tumor was poorly differenti-
ated carcinoma with mononuclear cells that were dif-
ferent from the primary pathological features. Metas-
tases usually reflect the histology of the primary tu-
mor.  These  alterations  suggest  that  multidirectional 
tumor was probably derived from aberrant differen-
tiation of the somatic epitherial cells of the endome-
trioid adenocarcinoma, or might occur from a com-
mon stem cell. However, further studies on the path-
ogenesis of mixed tumors are required to determine 
this issue. 
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